Copan and bioMérieux (Paris:BIM) announce today that they have signed an exclusive worldwide distribution agreement authorizing bioMérieux to market, for the pharmaceutical industry, an innovative sample collection system based on technology developed by Copan.
This patented product marks a major breakthrough because it is the first swab on the market that can be used to perform a quantitative environmental control. The unique texture of the Nylon™ flocked swab picks up more microorganisms than conventional swabs. This swab is protected by a triple sterile packaging designed specifically for aseptic manufacturing facilities.
